Possibilities of local injection therapy for work-associated knee osteoarthritis


DOI: https://dx.doi.org/10.18565/therapy.2025.1.64-73

Shokhin A.A., Trofimova A.S., Trofimov E.A.

1) Severodvinsk City Hospital No. 1; 2) I.I. Mechnikov North-Western State Medical University of the Ministry of Healthcare of Russia, Saint Petersburg
Abstract. Knee osteoarthritis (OA) is a common degenerative-inflammatory pathology of musculoskeletal system. Patients engaged in heavy physical labor, have more aggressive course of OA. Local injection therapy (LIT) is considered to be a promising method capable of providing a significant symptomatic effect in case of knee OA with minimization of systemic adverse reactions.
The aim: to estimate and compare the efficacy of intra-articular injections of hyaluronic acid (HA) and platelet-enriched plasma (PEP) in patients with knee OA associated with work activity.
Material and methods. In the frames of a randomized controlled study, data from 65 patients (35 females and 30 males) aged 30–55 years with knee OA stages I–II according to Kellgren – Lawrence, who had high work physical activity were analyzed. All the participants were divided into three groups: group 1 (n = 25) received diacerein, group 2 (n = 22) – diacerein and LIT HA, group 3 (n = 18) – diacerein and PEP. The criteria for efficacy were changes in pain syndrome (Visual Analogue Scale, VAS), functional test indexes (WOMAC, Lequesne index), need for non-steroidal anti-inflammatory drugs (NSAIDs), and ultrasound examination data. The observation was carried out for 24 weeks with regular visits and symptoms monitoring.
Results. The most significant clinical effect was achieved in patients from HA group: pain during work activities regressed by 47%, at rest – by 56%. The group using PEP also demonstrated a significant reduction in pain syndrome in both cases – by 36 and 45%, respectively. Among patients using diacerein monotherapy, similar indexes (25 and 35%) were statistically lower than in LIT groups. Concerning the improvement of functional scale values and reduction in need for NSAIDs, the group of patients receiving HA injections was also leading, ahead of the PEP therapy group. According to the data of ultrasound examination, no significant changes in cartilage thickness were observed in the compared groups during the study period. Reactive synovitis developed in some patients in PEP group.
Conclusion. Combined use of diacerein and HA is a preferred method of treating work-related knee OA not only because of its higher efficacy demonstrated in our study, but also because of the absolute sterility and standardized manufacturing technique of the HA drug injected into the joint cavity.

Literature


1. Клиническая ревматология. Руководство для врачей. 3-е издание, переработанное и дополненное. Под ред. В.И. Мазурова. М.: Е-ното. 2021; 696 с. (Clinical rheumatology. Guide for doctors. 3rd edition, revised and enlarged. Ed. by Mazurov V.I. Moscow: E-noto. 2021; 696 pp. (In Russ.)). ISBN: 978-5-906023-26-1.


2. World Health Organization. Chronic rheumatic conditions. 2020. URL: https://web.archive.org/web/20150427154245/http://www.who.int/chp/topics/rheumatic/en (date of access – 12.02.2025).


3. Felson D.T., Lawrence R.C., Dieppe P.A. et al. Osteoarthritis: New insights. Part 1: The disease and its risk factors. Ann Intern Med. 2000; 133(8): 635–46.


https://doi.org/10.7326/0003-4819-133-8-200010170-00016. PMID: 11033593.


4. Российские клинические рекомендации. Ревматология. Под ред. академика РАН Е.Л. Насонова. М.: ГЭОТАР-Медиа. 2020; 448 с. (Russian clinical guidelines. Rheumatology. Ed. by academician of RAS Nasonov E.L. Moscow: GEOTAR-Media. 2020; 448 pp. (In Russ.)). ISBN: 978-5-9704-5398-8.


5. Felson D.T. Clinical practice. Osteoarthritis of the knee. N Engl J Med. 2006; 354(8): 841–48.


https://doi.org/10.1056/NEJMcp051726. PMID: 16495396.


6. Goldring M.B., Otero M. Inflammation in osteoarthritis. Curr Opin Rheumatol. 2011; 23(5): 471–78.


https://doi.org/10.1097/BOR.0b013e328349c2b1. PMID: 21788902. PMCID: PMC3937875.


7. Kapoor M., Martel-Pelletier J., Lajeunesse D. et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011; 7(1): 33–42.


https://doi.org/10.1038/nrrheum.2010.196. PMID: 21119608.


8. Sandell L.J., Aigner T. Articular cartilage and changes in arthritis. An introduction: Cell biology of osteoarthritis. Arthritis Res. 2001; 3(2): 107–13.


https://doi.org/10.1186/ar148. PMID: 11178118. PMCID: PMC128887.


9. Lumeng C.N., Saltiel A.R. Inflammatory links between obesity and metabolic disease. J Clin Invest. 2011; 121(6): 2111–17.


https://doi.org/10.1172/JCI57132. PMID: 21633179. PMCID: PMC3104776.


10. Dieppe P.A., Lohmander L.S. Pathogenesis and management of pain in osteoarthritis. Lancet. 2005; 365(9463): 965–73.


https://doi.org/10.1016/S0140-6736(05)71086-2. PMID: 15766999.


11. Трофимова А.С., Мазуров В.И., Шохин А.А., Трофимов Е.А. Применение симптоматических средств замедленного действия при остеоартрите суставов кистей: акцент на параметры микроциркуляции. Научно-практическая ревматология. 2024; 62(1): 104–108. (Trofimova A.S., Mazurov V.I., Shokhin A.A., Trofimov E.A. The use of symptomatic slow-acting drugs for osteoarthritis of the joints of the hands: accent on microcirculation parameters. Nauchcno-practicheskaya revmatologiya = Rheumatology Science and Practice. 2024; 62(1): 104–108 (In Russ.)).


https://doi.org/10.47360/1995-4484-2024-104-108. EDN: KOMTFW.


12. Burr D.B., Gallant M.A. Bone remodelling in osteoarthritis. Nat Rev Rheumatol. 2012; 8(11): 665–73.


https://doi.org/10.1038/nrrheum.2012.130. PMID: 22868925.


13. Насонова В.А., Мендель О.И., Денисов Л.Н. с соавт. Остеоартроз и ожирение: клинико-патогенетические взаимосвязи. Профилактическая медицина. 2011; 14(1): 29–37. (Nasonova V.A., Mendel’ O.I., Denisov L.N. et al. Osteoarthrosis and obesity: Clinical and pathogenetic associations. Profilakticheskaya meditsina = Russian Journal of Preventive Medicine. 2011; 14(1): 29–37 (In Russ.)). EDN: PUGJDV.


14. McWilliams D.F., Leeb B.F., Muthuri S.G. et al. Occupational risk factors for osteoarthritis of the knee: A meta-analysis. Osteoarthritis Cartilage. 2011; 19(7): 829–839.


https://doi.org/10.1016/j.joca.2011.02.016. PMID: 21382500.


15. Шохин А.А., Трофимов Е.А. Остеоартрит, ассоциированный с профессией: современное представление проблемы. В кн.: Боткинские чтения. Сборник тезисов Всероссийского терапевтического конгресса с международным участием. СПб. 2024; 271–272. (Shokhin A.A., Trofimov E.A. Occupational osteoarthritis: Modern view of the problem. In the book: Botkin readings. Collection of articles abstracts of the All-Russian therapeutic congress with international participation. Saint Petersburg. 2024; 271–272 (In Russ.)). EDN: CKUDTW.


16. Лила А.М., Алексеева Л.И., Таскина Е.А. Современные подходы к терапии остеоартрита с учетом обновленных международных рекомендаций. РМЖ. Медицинское обозрение. 2019; 3(11-2): 48–52. (Lila A.M., Alekseeva L.I., Taskina E.A. Modern approaches to osteoarthritis therapy taking into account updated international guidelines. Russkiy meditsisnkiy zhurnal. Meditsinskoye obozreniye = Russian Medical Journal. Medical Review. 2019; 3(11-2): 48–52 (In Russ.)). EDN: ZBVXMF.


17. Primorac D., Molnar V., Rod E. et al. Knee osteoarthritis: A review of pathogenesis and state-of-the-art non-operative therapeutic considerations. Genes (Basel). 2020; 11(8): 854.


https://doi.org/10.3390/genes11080854. PMID: 32722615. PMCID: PMC7464436.


18. Самусев С.Р., Маланин Д.А., Новочадов В.В., Беликов А.А. Комплексная оценка эффективности вискосапплиментарной терапии у больных с гонартрозом. Волгоградский научно-медицинский журнал. 2008; (4): 51–55. (Samusev S.R., Malanin D.A., Novoсhadov V.V., Belikov A.A. Comprehensive assessment of the effectiveness of viscosupplementation therapy in patients with gonarthrosis. Volgogradskiy nauchno-meditsinskiy zhurnal = Volgograd Scientific Medical Journal. 2008; (4): 51–55 (In Russ.)). EDN: TRPKGR.


19. Sánchez M., Anitua E., Padilla S. et al. Plasma rich in growth factors for the treatment of osteoarthritis: An overview of the clinical evidence. BioDrugs. 2019; 33(4): 305–19.


20. Altman R.D., Manjoo A., Fierlinger A. et al. The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: A systematic review. BMC Musculoskelet Disord. 2015; 16: 321.


https://doi.org/10.1186/s12891-015-0775-z. PMID: 26503103. PMCID: PMC4621876.


21. Filardo G., Kon E., Buda R. et al. Platelet-rich plasma intra-articular injections for cartilage degeneration and osteoarthritis: From preclinical to clinical evidence. Arthroscopy. 2015; 31(11): 2053–63.


22. Campbell K.A., Saltzman B.M., Mascarenhas R. et al. Does intra-articular platelet-rich plasma injection provide clinically superior outcomes compared with other therapies in the treatment of knee osteoarthritis? A systematic review of overlapping meta-analyses. Arthroscopy. 2015; 31(11): 2213–21.


https://doi.org/10.1016/j.arthro.2015.03.041. PMID: 26033459.


23. Toghraie F., Rashtchi V., Dehghani S. et al. Platelet-rich plasma for the treatment of knee osteoarthritis: An overview of systematic reviews. Orthop Res Rev. 2019; 11: 55–68.


24. Yu W., Xu P., Huang G., Liu L. Clinical therapy of hyaluronic acid combined with platelet‑rich plasma for the treatment of knee osteoarthritis. Exp Ther Med. 2018; 16(3): 2119–25.


https://doi.org/10.3892/etm.2018.6412. PMID: 30186448. PMCID: PMC6122407.


25. Стребкова Е.А., Алексеева Л.И. Остеоартроз и ожирение. Научно-практическая ревматология. 2015; 53(5): 542–552. (Strebkova E.A., Alekseeva L.I. Osteoarthritis and obesity. Nauchcno-practicheskaya revmatologiya = Rheumatology Science and Practice. 2015; 53(5): 542–552 (In Russ.)).


https://doi.org/10.14412/1995-4484-2015-542-552. EDN: UMIDVF.


26. Прохорова И.Е., Артеменко Н.А., Багмет А.Д. Клинические и лабораторные особенности течения остеоартроза у пациентов с ожирением. Военно-медицинский журнал. 2009; 220(3): 73. (Prokhorova I.E., Artemenko N.A., Bagmet A.D. Clinical and laboratory features of osteoarthritis in patients with obesity. Voenno-meditsinskiy zhurnal = Military Medical Journal. 2009; 220(3): 73 (In Russ.)). EDN: STTWBZ.


27. Faletti C., Mussa F., Autelli R. et al. Nonpharmacological treatments and lifestyle interventions in osteoarthritis. J Orthop Traumatol. 2020; 21(2): 45–52.


28. Bindu S., Mazumder S., Bandyopadhyay U. Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective. Biochem Pharmacol. 2020; 180: 114147.


https://doi.org/10.1016/j.bcp.2020.114147. PMID: 32653589. PMCID: PMC7347500.


29. Guler O., Mutlu S., Isyar M. et al. Comparison of short-term results of intraarticular platelet-rich plasma (PRP) and hyaluronic acid treatments in early-stage gonarthrosis patients. Eur J Orthop Surg Traumatol. 2015; 25(3): 509–13.


https://doi.org/10.1007/s00590-014-1517-x. PMID: 25085316.


30. Pavelka K., Bruyère O., Cooper C. et al. Diacerein: Benefits, risks and place in the management of osteoarthritis. An opinion-based report from the ESCEO. Drugs Aging. 2016; 33(2): 75–85.


https://doi.org/10.1007/s40266-016-0347-4. PMID: 26849131. PMCID: PMC4756045.


31. Moldovan F., Pelletier J.P., Jolicoeur F.C. et al. Diacerhein and rhein reduce the ICE-induced IL-1β and IL-18 activation in human osteoarthritic cartilage. Osteoarthritis Cartilage. 2000; 8(3): 186–96.


https://doi.org/10.1053/joca.1999.0289. PMID: 10806046.


About the Autors


Andrey A. Shokhin, MD, rheumatologist at Severodvinsk City Hospital No. 1. Address: 164504, Severodvinsk, 47 Lomonosova St.
E-mail: andra.11@yandex.ru
ORCID: https://orcid.org/0009-0000-5440-237X. eLibrary SPIN: 8922-1101
Anna S. Trofimova, MD, PhD (Medicine), assistant at the Department of therapy, rheumatology, examination of temporary disability and quality of medical care with a course in hematology and transfusiology named after E.E. Eichwald, I.I. Mechnikov North-West State Medical University of the Ministry of Healthcare of Russia. Address: 191015, Saint Petersburg, 41 Kirochnaya St.
E-mail: Anna.Trofimova@szgmu.ru
ORCID: https://orcid.org/0000-0001-5926-7912. eLibrary SPIN: 6827-3934
Evgeny A. Trofimov, MD, Dr. Sci. (Medicine), professor, professor of the Department of therapy, rheumatology, examination of temporary disability and quality of medical care with a course in hematology and transfusiology named after E.E. Eichwald, I.I. Mechnikov North-West State Medical University of the Ministry of Healthcare of Russia. Address: 191015, Saint Petersburg, 41 Kirochnaya St.
E-mail: Evgeniy.trofimov@szgmu.ru
ORCID: https://orcid.org/0000-0003-3236-4485. eLibrary SPIN: 4358-1663


Similar Articles


Бионика Медиа